Broadcasting and Cable talked to HBO Programming Group President Michael Lombardo [in an article that is no longer available at their website] and reports the following as of June 8:
The future of In Treatment has yet to be decided. Producers and HBO executives will meet this week to discuss the possibility of a third season. The Gabriel Byrne drama attracts a small audience, averaging about 1.6 million viewers. While the show is cheap to produce, a third season would be significantly more expensive. More writers would have to be hired to create scripts, as HBO has now exhausted all of the material from the original Israeli series. And Byrne’s rate would likely increase. The actor has talked openly about his fatigue due to the show’s arduous shooting schedule.
Lombardo declines to characterize prospects for renewal, but he stresses that In Treatment‘s passionate fan base is a factor.
You betcha! The fan base is definitely passionate, though the numbers might be slimmer than we would like.
Cross your fingers, everyone! Sounds like a decision will be forthcoming very soon.